Madecassoside

Star0

DB15532InvestigationalSmall molecule

Madecassoside: Overview.

Formula / weight: C₄₈H₇₈O₂₀ · 975.132 g/mol (avg)
Also known as: Asiaticoside A · Redermic

Resolves to

Compound

UNIICQ2F5O6YIYCAS34540-22-2ChEBI66651

Clinical / RWD

RxNorm87855

Structure

InChIKeyBNMGUJRJUUDLHW-HCZMHFOYSA-NSMILES

[H][C@@]1(O[C@@H]2[C@@H](CO)O[C@@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CC[C@@H](C)[C@H](C)[C@@]4([H])C4=CC[C@]6([H])[C@@]7(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@]7([H])[C@H](O)C[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@H]2O)O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O

Targets

O60603TLR2O00206TLR4

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

4Marketed productsAcross 1 country and 3 labellers

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Madecassoside, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account